NASDAQ:EVLO Evelo Biosciences (EVLO) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range$0.00▼$0.0652-Week Range N/AVolume82,848 shsAverage Volume6,348 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Get Evelo Biosciences alerts: Email Address Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Evelo Biosciences Stock (NASDAQ:EVLO)Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.Read More Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. EVLO Stock News HeadlinesJuly 25 at 1:19 AM | americanbankingnews.comStock Traders Buy Large Volume of Evelo Biosciences Put Options (NASDAQ:EVLO)February 22, 2024 | benzinga.comEvelo Biosciences Stock (OTC:EVLO), Short Interest ReportJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! November 24, 2023 | msn.comEvelo Biosciences, a microbiome company launched by Flagship, shuts downNovember 22, 2023 | bizjournals.comFlagship-backed startup Evelo, behind failed eczema drug, to dissolveNovember 14, 2023 | finance.yahoo.comFMR LLC Reduces Stake in Evelo Biosciences IncNovember 10, 2023 | morningstar.comEvelo Biosciences Inc EVLONovember 2, 2023 | finance.yahoo.comQ3 2023 Horizon Technology Finance Corp Earnings CallJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! November 2, 2023 | finance.yahoo.comHorizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call TranscriptNovember 1, 2023 | msn.comEvelo Biosciences (EVLO) Price Target Increased by 53.85% to 10.20October 19, 2023 | msn.comTD Cowen Downgrades Evelo Biosciences (EVLO)October 18, 2023 | finance.yahoo.comEvelo (EVLO) Drops 59% on Flunking Psoriasis Drug StudyOctober 17, 2023 | marketwatch.comEvelo Biosciences Shares Down 58% After Unfavorable EDP2939 ResultsOctober 17, 2023 | markets.businessinsider.comHold Rating on Evelo Biosciences amid Unfavorable Outcomes and Strategic Changes: An Analyst Recommendation ReportOctober 17, 2023 | seekingalpha.comEvelo drops as mid-stage trial for psoriasis drug failsOctober 17, 2023 | proactiveinvestors.comEvelo Biosciences shares tank 46% after trial failureOctober 17, 2023 | markets.businessinsider.comEvelo Biosciences: EDP2939-101 Study Fails To Meet Endpoint; To Explore Strategic AlternativesSee More Headlines Receive EVLO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2021Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:EVLO CUSIPN/A CIK1694665 Webwww.evelobio.com Phone(617) 577-0300FaxN/AEmployees120Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.92) per share Price / BookN/AMiscellaneous Outstanding Shares18,980,000Free Float18,789,000Market CapN/A OptionableNo Data Beta1.58 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Craig R. Jalbert CIRA (Age 62)President, Secretary, Principal Executive, Financial and Accounting Officer & Director Dr. Chun Zhang Ph.D.Chief Technical Operations & Quality OfficerDr. Mark Bodmer Ph.D. (Age 66)Chief Scientific Officer and President of Research & Development Comp: $668.8kMs. Jessica CotroneVP & Head of CommunicationsMs. Leslie Wardwell-Scott Ph.D.VP and Head of Corporate Development & Strategic IntegrationDr. Andrea Itano Ph.D.Head of ResearchDr. Duncan McHale M.D. (Age 57)MBBS, Ph.D., Chief Medical Officer Comp: $661.97kMr. Douglas MaslinSenior Director & Immunology Clinical LeadMore ExecutivesKey CompetitorsAesther Healthcare AcquisitionNASDAQ:AEHAWGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPView All CompetitorsInsidersMark BodmerSold 3,163 sharesTotal: $1,043.79 ($0.33/share)Marella ThorellSold 1,811 sharesTotal: $597.63 ($0.33/share)Simba GillSold 172 sharesTotal: $56.76 ($0.33/share)Simba GillSold 1,996 sharesTotal: $7,864.24 ($3.94/share)Mark BodmerSold 3,128 sharesTotal: $29,747.28 ($9.51/share)View All Insider Transactions EVLO Stock Analysis - Frequently Asked Questions How were Evelo Biosciences' earnings last quarter? Evelo Biosciences, Inc. (NASDAQ:EVLO) issued its quarterly earnings data on Wednesday, October, 27th. The company reported ($12.60) earnings per share for the quarter, missing the consensus estimate of ($10.80) by $1.80. When did Evelo Biosciences' stock split? Evelo Biosciences's stock reverse split on the morning of Friday, June 30th 2023. The 1-20 reverse split was announced on Friday, June 30th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 30th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Evelo Biosciences IPO? Evelo Biosciences (EVLO) raised $85 million in an initial public offering (IPO) on Wednesday, May 9th 2018. The company issued 5,300,000 shares at $15.00-$17.00 per share. Morgan Stanley, Cowen and BMO Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager. How do I buy shares of Evelo Biosciences? Shares of EVLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Evelo Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evelo Biosciences investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Evofem Biosciences (EVFM), Sorrento Therapeutics (SRNE), Cerecor (CERC), Myovant Sciences (MYOV) and Provention Bio (PRVB). This page (NASDAQ:EVLO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVLO Stock Alerts